From: Combating poor-quality anti-malarial medicines: a call to action
Prioritize the development of medical products regulation |
Strengthen the coherence and performance of the medicines regulatory system (including dialogue among stakeholders)a |
Adapt and use guidelines in line with WHO recommendations |
Increase implementation of regulatory functions |
Enhance the status of NMRAs |
Institute sustainable mechanisms to effectively manage conflicts of interest |
Strengthen inter-sectoral collaboration between relevant stakeholders |
Ensure availability of qualified human resources for regulation of medical products |
Ensure adequate and sustainable financing of the medicines regulatory system |
Improve collaboration, coordination, and harmonization of medical products regulation |